TransMedics Group, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
TransMedics Group, Inc. (TMDX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$44.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24
- TransMedics Group, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$44.70M.
- TransMedics Group, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $15.10M, a 151.67% increase from fiscal 2020.
- TransMedics Group, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $6.00M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$44.70M 10-K · filed 2026-02-24 |
| 2021-12-31 | $15.10M 10-K · filed 2022-03-01 |
| 2020-12-31 | $6.00M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |